General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-01 | 2024-03 | -0.04 | -0.01 | 0.03 | 75.00% |
2024-02-29 | 2023-12 | -0.04 | N/A | N/A | N/A |
2023-11-01 | 2023-09 | -0.02 | N/A | N/A | N/A |
2023-08-02 | 2023-06 | -0.02 | 0.02 | 0.04 | 200.00% |
2023-05-03 | 2023-03 | -0.01 | 0.02 | 0.03 | 300.00% |
2023-03-01 | 2022-12 | 0.01 | 0.02 | 0.01 | 100.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-07-19 | Goldman Sachs | Upgrade | Sell | Sell |
2023-07-18 | Northland Capital Markets | Upgrade | Market Perform | Market Perform |
2023-01-05 | Jefferies | Upgrade | Hold | Buy |
2022-10-18 | SVB Leerink | Upgrade | Market Perform | |
2022-05-23 | Goldman Sachs | Upgrade | Sell | |
2022-05-05 | JP Morgan | Downgrade | Neutral | Underweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-01-30 | BERG AARON D. | Officer | 633.26K | Conversion of Exercise of derivative security |
2024-01-21 | HOLT PATRICK | Chief Executive Officer | 314.43K | Purchase |
2022-07-28 | KALB MICHAEL WAYNE | Chief Financial Officer | 337.31K | Conversion of Exercise of derivative security |
2024-01-30 | KETCHUM STEVEN B | Officer | 658.72K | Conversion of Exercise of derivative security |
2022-08-18 | MARKS JASON M | Officer | 21.92K | Conversion of Exercise of derivative security |
2023-02-20 | MIKHAIL KARIM | Chief Executive Officer | 283.51K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Kynam Capital Management, LP | 12.00M | 14.28M | 12.15% |
2023-06-29 | Morgan Stanley | 11.28M | 13.42M | 11.41% |
2023-06-29 | Eversept Partners, LP | 10.50M | 12.50M | 10.63% |
2023-06-29 | Tang Capital Management, LLC | 7.10M | 8.45M | 7.19% |
2023-06-29 | SCP Investment, LP | 6.50M | 7.74M | 6.58% |
2023-06-29 | DG Capital Management, LLC | 5.47M | 6.51M | 5.54% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Northern Lights Fd Tr-13D Activist Fd | 3.81M | 4.53M | 3.85% |
2023-06-29 | Mutual Fund Ser Tr-AlphaCentric LifeSci Healthcare Fund | 585.00K | 696.15K | 0.59% |
2023-06-29 | Legg Mason Clearbridge Small Cap Value Fd | 531.07K | 631.97K | 0.54% |
2023-06-29 | Columbia Fds Var Ser Tr II-Columbia Var Port-Overseas Core Fd | 458.93K | 546.12K | 0.46% |
2023-05-30 | Columbia Fds Ser Tr-Columbia Overseas Value Fd | 315.88K | 369.58K | 0.32% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 214.39K | 250.83K | 0.22% |
Split | Date |
---|---|
0.1 : 1 | 2008-01-18 |
0.1 : 1 | 1998-10-19 |
$18.06 after dilution? Is that the best bears can do? I’ll give them credit, you have to have BIG balls to short this. Any day we wake up and FDA has approved label expansion. Good night and big balls
“Remember all the bears who spewed doom and gloom that got burned and are now living in a van down by the river? Glad I stayed long” ~ Amarin Longs (come Jan 2020)
Alert! Possible BO between $2-$200pps in the next 12-24 months. Book it!
$18 offering? I need some Vescepa
An additional $400m and this just touched $20pps? 1 month ago this was at $18pps without the added $400m offering. Bears are screwed. Labor Day we should be firing up the grill for some bear meat
If this ultimately winds up around $20 in the next week that will be well worth it. $20-$22pps, additional $400m on hand with double the sales force, no debt and label expansion approval. This company would look pretty strong on paper come 10/1 for someone looking to buy
I would imagine the dilution is to help the big institutions to pick up more shares at a low price just before BO. Probably already discussed during the BO negotiations
Raised projection from $350m to $480m and then offer dilution of $400m a few weeks later?
“Bad fish! Not like going down to the pond and chasing bluegills or tommycods. This fish, swallow ya whole. A little shakin, a little tenderizin, down you go” ~ Quint
Stop whining, go on vacation and come back in September
Come on $20.75
Shorts like Robert Skunking are posting again. Just ignore. BO deal is already done...just contingent on label expansion approval. Wait for it.....
I miss Jordan. Need a good laugh today
Come on $20.75. Need to load up!
I’m long but want more shares. Come on baby......drop below $20
BO or partner?
Is everyone here delusional that BP “will” be interested? Most likely there is already a deal in place contingent on FDA Label Expansion. I would be shocked if that is not the case
I miss Frank
Words of wisdom
Gotta agree with the shorts. Good possibility this ends red. MMs keeping it down until BO. This will go lower.
Get ready for cheap shares. Good news always makes this drop.